La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Nicotinic receptors in the brain. Molecular biology, function, and therapeutics.

Identifieur interne : 001E30 ( Ncbi/Curation ); précédent : 001E29; suivant : 001E31

Nicotinic receptors in the brain. Molecular biology, function, and therapeutics.

Auteurs : C. Vidal [France]

Source :

RBID : pubmed:8871936

English descriptors

Abstract

Although the psychological and physiological effects of nicotine have long suggested that nicotine exerts specific actions in the brain, the identification of neuronal nicotinic receptors (nAChRs) only began in the past few years with the development of molecular genetics. It is now clear that neuronal nAChRs form a family of highly heterogenous receptor subtypes, as evidenced by the number of genes encoding nAChR subunits, the diversity of immunopurified receptor proteins, and the multiple functional types of ligand-gated ion channels. Neuronal nAChRs have discrete localizations within the brain, and are involved in modulating neuronal firing and transmitter release. Cumulative evidence from animal and human studies indicates that nicotinic systems play a major role in higher cognitive functions and dysfunctions. In particular, the loss of cortical nAChRs is a neuro-chemical hallmark of Alzheimer (AD) and Parkinson (PD) diseases. In addition, nicotine improves memory and attention in Ad and PD. Our recent studies using electrophysiological biochemical and behavioral approaches suggest that the prefrontal cortex is a major target site for the cognitive actions of nicotine.

DOI: 10.1007/BF02815199
PubMed: 8871936

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:8871936

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Nicotinic receptors in the brain. Molecular biology, function, and therapeutics.</title>
<author>
<name sortKey="Vidal, C" sort="Vidal, C" uniqKey="Vidal C" first="C" last="Vidal">C. Vidal</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut Pasteur, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="????">
<PubDate>
<MedlineDate>1996 May-Aug</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:8871936</idno>
<idno type="pmid">8871936</idno>
<idno type="doi">10.1007/BF02815199</idno>
<idno type="wicri:Area/PubMed/Corpus">001579</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001579</idno>
<idno type="wicri:Area/PubMed/Curation">001538</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001538</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001538</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001538</idno>
<idno type="wicri:Area/Ncbi/Merge">001E30</idno>
<idno type="wicri:Area/Ncbi/Curation">001E30</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Nicotinic receptors in the brain. Molecular biology, function, and therapeutics.</title>
<author>
<name sortKey="Vidal, C" sort="Vidal, C" uniqKey="Vidal C" first="C" last="Vidal">C. Vidal</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut Pasteur, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Molecular and chemical neuropathology</title>
<idno type="ISSN">1044-7393</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Brain (physiology)</term>
<term>Brain Mapping</term>
<term>Cerebral Cortex (physiology)</term>
<term>Cognition</term>
<term>Hippocampus (physiology)</term>
<term>Humans</term>
<term>Neurons (physiology)</term>
<term>Receptors, Nicotinic (biosynthesis)</term>
<term>Receptors, Nicotinic (physiology)</term>
<term>Vertebrates</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Receptors, Nicotinic</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Brain</term>
<term>Cerebral Cortex</term>
<term>Hippocampus</term>
<term>Neurons</term>
<term>Receptors, Nicotinic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Brain Mapping</term>
<term>Cognition</term>
<term>Humans</term>
<term>Vertebrates</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Although the psychological and physiological effects of nicotine have long suggested that nicotine exerts specific actions in the brain, the identification of neuronal nicotinic receptors (nAChRs) only began in the past few years with the development of molecular genetics. It is now clear that neuronal nAChRs form a family of highly heterogenous receptor subtypes, as evidenced by the number of genes encoding nAChR subunits, the diversity of immunopurified receptor proteins, and the multiple functional types of ligand-gated ion channels. Neuronal nAChRs have discrete localizations within the brain, and are involved in modulating neuronal firing and transmitter release. Cumulative evidence from animal and human studies indicates that nicotinic systems play a major role in higher cognitive functions and dysfunctions. In particular, the loss of cortical nAChRs is a neuro-chemical hallmark of Alzheimer (AD) and Parkinson (PD) diseases. In addition, nicotine improves memory and attention in Ad and PD. Our recent studies using electrophysiological biochemical and behavioral approaches suggest that the prefrontal cortex is a major target site for the cognitive actions of nicotine.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E30 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001E30 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:8871936
   |texte=   Nicotinic receptors in the brain. Molecular biology, function, and therapeutics.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:8871936" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024